About
Overview
Company Leadership
Science
Technology Platform
Scientific Publications
Pipeline
Overview
CF101
CF102
CF602
Investor Information
Overview
News / Events
Company Information
Financial Information
Stock Information
SEC Filings
Corporate Governance
Shareholders Meetings
Contact Us
Directions
Investor Information
Overview
News / Events
Press Releases
In The News
Research
Events Calendar
Presentations
Email Alerts
Company Information
Profile
Management
IR Contacts
FAQ
Financial Information
Quarterly & Annual Reports
Stock Information
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Section 16 Filings
Corporate Governance
Board of Directors
Governance Docs
Shareholders Meetings
Email Alerts
IR Contacts
RSS News Feed
Press Releases
All News
By Year:
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Jul 20, 2020 7:00 AM EDT
Can-Fite Completes Development of an Assay to Identify Clinically Active Cannabis Derived Compounds
Jul 15, 2020 7:00 AM EDT
Can-Fite Completes Phase II COVID-19 Protocol Based on FDA Guidance, Plans to File IND Shortly
Jul 6, 2020 8:00 AM EDT
Can-Fite Announces $3.4 Million Registered Direct Offering
Jun 30, 2020 7:00 AM EDT
Can-Fite Announces Final Data Analysis from Phase II NASH Study: Highly Significant and Sustained Reduction in Liver Fat Volume Throughout Study Period
Jun 10, 2020 8:00 AM EDT
Can-Fite Announces $8.0 Million Registered Direct Offering
Jun 9, 2020 7:00 AM EDT
Following Pre-IND Guidance from FDA Can-Fite to Advance Piclidenoson into Phase II COVID-19 Trial in the U.S.
Jun 8, 2020 7:25 AM EDT
Can-Fite Participating in BIO Digital International Convention and One-on-One Partnering Meetings on June 8-12, 2020
Jun 4, 2020 7:14 AM EDT
Can-Fite Concludes Successful Meeting with European Medicines Agency (EMA) Regarding Phase III Trial and Registration Plan for Namodenoson in the Treatment of Liver Cancer
Jun 3, 2020 7:00 AM EDT
Can-Fite BioPharma to Hold Investor Webinar and Q&A Session with CEO on June 4th
Jun 1, 2020 7:00 AM EDT
Can-Fite Reports First Quarter 2020 Financial Results & Provides Clinical Update
<< Previous
1
2
3
4
5
6
7
8
9
10
...30
Next >>
Show All